Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Dapagliflozin
Related studies linked through entity extraction aliases.
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
- Status
- COMPLETED
- Phase
- PHASE3
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
- Status
- COMPLETED
- Phase
- PHASE3
A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood Glucose
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects
- Status
- TERMINATED
- Phase
- PHASE1
A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
- Status
- COMPLETED
- Phase
- PHASE1
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State
- Status
- COMPLETED
- Phase
- PHASE1
Dapagliflozin DPPIV Inhibitor add-on Study
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1